PT Merck Tbk

Rp 3,490As of Sun 8 Nov 2026, 12:00 UTC
IDX:MERKHealthcare
Country Indonesia
PE (Fwd) •••
TSR 10Y CAGR (0.67%)
Div yield 7.88%
ROE 26.76%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.19
PE TTM 6.555
TSR TTM 31.39%
Mkt cap Rp 1.564T
ROIC 39.01%
SE Grade™
Value
Quality
Moat
Consensus
Reference
Rp 3,404
(2.46%)
137.08%
Hold 8|12|12|11|11
4Q25
1Q26
2Q26
3Q26
Earnings per shareRp
42.50
42.15
42.50
46.61
18.67%
8.74%
3.12%
16.89%
RevenueRp B
72.60
76.49
76.88
78.51
(0.94%)
1.34%
3.08%
5.61%
Peers (US$86.37M)
Cap (US$)
PE
97.13M
12.36x
21.57M
18.12x
85.49M
—
Capital
TTM
5Y
10Y
Leveragex
0.719
(0.050)
(0.063)
EBIT/Intx
0.633
1.192
0.989
Own earn%
(106.21)
(14.26)
(17.00)
Sh yield%
37.26
37.10
37.17
Owners
Insiders/Inst%
13.32
53.24
Short interest%
0.57
SBC / revenue%
2.95
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
2–9
$1 testx
−0.1
Incr. ROIC%
11